AFJKR Aimei Health Technology Co., Ltd - Fundamental Analysis

BEARISH

AFJKR Stock | Fundamental Analysis & Investment Insights

NASDAQ • N/A • N/A

Current Price Live

$0.39

52W High

$0.4

52W Low

$0.35

Overview AI Snowflake Price Valuation Profitability Growth Health Ownership

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Feb 14, 2026

Market cap

N/A

P/E

N/A

ROE

N/A

Profit margin

N/A

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

Confidence Score

92%

Analysis Accuracy

AFJKR exhibits severe financial distress, as evidenced by a Piotroski F-Score of 3/9, indicating weak operational and financial health. The absence of an Altman Z-Score and a negative ROA of -1.04% further signal deteriorating fundamentals. With a current price of $0.39 trading below its 52-week low of $0.35, the stock shows no growth momentum, declining earnings, and near-zero liquidity, reflected in a current ratio of 0.01 and quick ratio of 0.00. The lack of profitability, negative price-to-book ratio, and no analyst coverage underscore deep value and risk concerns.

Key Strengths

Trading near 52-week low may present a technical bounce opportunity

Low market cap could enable speculative upside if turnaround occurs

Insider sentiment at 40/100 suggests neutral to cautious positioning

Price is below 52-week high, indicating potential oversold condition

No dividend payout reduces financial burden (though not a strength)

Key Risks

Piotroski F-Score of 3/9 indicates poor financial health and operational inefficiency

Negative ROA (-1.04%) and zero margins signal sustained unprofitability

Extremely weak liquidity: current ratio of 0.01 and quick ratio of 0.00

Earnings declined by 30.20% YoY and 52.70% Q/Q, indicating accelerating deterioration

No analyst coverage and no target price imply lack of institutional interest or confidence

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

High Risk

Key drivers: Low Piotroski F-Score (3/9), Negative ROA and zero margins, Extreme liquidity constraints, Declining earnings and revenue trends, No analyst coverage or valuation benchmarks

Confidence

95%

Value

15/100

Ref P/E, PEG, Graham Number

Positives

Trading below 52-week high
Low price ($0.39) may appeal to deep value investors

Watchpoints

No Graham Number or intrinsic value estimate available
Negative Price/Book (-0.69) indicates asset value below equity
No P/E, PEG, or sales-based valuation metrics

Future

10/100

Ref Growth rates

Positives

Potential for turnaround if new business model or funding is introduced

Watchpoints

Earnings down 30.20% YoY and 52.70% Q/Q
No revenue growth data, but declining earnings suggest contraction
No forward guidance or growth indicators

Past

30/100

Ref Historical trends

Positives

Price has remained stable near $0.35–$0.40 for years (5Y change: +0.0%)

Watchpoints

Persistent unprofitability and negative ROA
Zero operating cash flow and free cash flow
No improvement in financial ratios over time

Health

12/100

Ref Altman Z-Score, Piotroski F-Score

Positives

No reported debt (though data missing)

Watchpoints

Piotroski F-Score of 3/9 (weak)
No Altman Z-Score available, but liquidity ratios suggest distress
Current ratio of 0.01 and quick ratio of 0.00 indicate inability to meet short-term obligations
Negative ROA and zero margins reflect poor capital efficiency

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

No dividend yield, rate, or payout ratio
Dividend strength is 0/100, indicating no dividend policy

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$0.39

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AFJKR and closest competitors.

Updated 2026-02-13

Company	5Y	3Y	1Y	6M	1M	1W
AFJKR Aimei Health Technology Co., Ltd Primary	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

-0.69

N/A

Profitability

Profit margins and return metrics

Profit Margin N/A

Operating Margin N/A

Gross Margin N/A

ROE N/A

ROA -1.04%

Growth

Revenue and earnings growth rates

Revenue Growth N/A

Earnings Growth -30.2%

Q/Q Revenue Growth N/A

Q/Q Earnings Growth -52.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

0.01

Weak

Quick Ratio

0.0

Poor

Cash/Share

$N/A

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Harraden Circle Investments, LLC

1,248,414 shares • 2025-09-30

Toronto Dominion Bank

1,524,525 shares • 2025-09-30

Clear Street Group Inc.

390,151 shares • 2025-09-30

Westchester Capital Management, LLC

288,212 shares • 2025-09-30

Shaolin Capital Management LLC

199,220 shares • 2025-09-30

RiverNorth Capital Management, LLC

172,789 shares • 2025-09-30

Shaw D.E. & Co., Inc.

155,000 shares • 2025-09-30

Wolverine Asset Management, LLC

312,643 shares • 2025-12-31

Past News Coverage

Recent headlines mentioning AFJKR from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends